Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aripiprazole - VS Pharmatech

Next Previous
Drug Profile

Aripiprazole - VS Pharmatech

Alternative Names: VS-101 - VS Pharmatech

Latest Information Update: 02 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator VS PharmTech
  • Class Antidepressants; Antipsychotics; Behavioural disorder therapies; Chemosensitisers; Chlorobenzenes; Mood stabilisers; Piperazines; Quinolines; Radiosensitisers; Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Squamous cell cancer
  • Preclinical Pancreatic cancer

Most Recent Events

  • 02 Mar 2026 VS 101 is still in phase I trials for Squamous cell cancer in South Korea (PO, Tablet) (KCT0007606)
  • 24 Feb 2026 Phase-II clinical trials in Squamous cell cancer (Combination therapy, Late-stage disease) in USA (unspecified route) (NCT06959082)
  • 28 Oct 2025 No recent reports of development identified for phase-I development in Squamous cell cancer in South Korea (PO, Tablet)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top